Prescription Volume Climbs After Holiday Lull, Led by GLP-1s and Specialty Biologics
Prescription activity in the United States increased in the week ending June 5, reversing a Memorial Day-related slowdown. The overall U.S. drug market rose 10% week-over-week after a prior weekly decline of 8%. GLP-1 medicines including tirzepatide and semaglutide posted strong year-over-year prescription gains, while several specialty biologics a…